Live Markets

Loading markets...

#semaglutide

GLP-1 Breakthrough: Semaglutide Can Reverse Osteoarthritis

GLP-1 Breakthrough: Semaglutide Can Reverse Osteoarthritis

April 28, 2026

US Launches VITAL-H Clinical Trial: Can Three Drugs Stop Aging?

US Launches VITAL-H Clinical Trial: Can Three Drugs Stop Aging?

April 19, 2026

Breaking: Semaglutide Muscle Loss Study Sparks Warning for Seniors

Breaking: Semaglutide Muscle Loss Study Sparks Warning for Seniors

April 17, 2026

Generic Ozempic FDA Approval: A Breakthrough for Aging

Generic Ozempic FDA Approval: A Breakthrough for Aging

April 10, 2026

Semaglutide Mental Health Benefits: Depression Risk Cut 44%

Semaglutide Mental Health Benefits: Depression Risk Cut 44%

April 06, 2026

Massive Study: Semaglutide for Depression Shows 44% Drop

Massive Study: Semaglutide for Depression Shows 44% Drop

April 05, 2026

Semaglutide Breakthrough: 44% Drop in Depression Risk

Semaglutide Breakthrough: 44% Drop in Depression Risk

April 05, 2026

Semaglutide Mental Health Benefits: Risks Slashed by 44%

Semaglutide Mental Health Benefits: Risks Slashed by 44%

April 04, 2026

Ozempic Depression Study 2026: GLP-1s Cut Mental Health Risks 42%

Ozempic Depression Study 2026: GLP-1s Cut Mental Health Risks 42%

April 01, 2026

VITAL-H Clinical Trial: The $38M Test of Longevity Drugs for Seniors

VITAL-H Clinical Trial: The $38M Test of Longevity Drugs for Seniors

March 18, 2026